Five-year follow-up results from the Phase 3 Study 309/KEYNOTE-775, presented at ESMO 2025, confirm that lenvatinib plus ...

A large AI-driven study of 3,476 cancer patients, presented at ESMO 2025, reveals that thymic health is strongly linked to ...

A new PNAS study unveils a hidden vulnerability of prostate cancer: the protein-disulfide isomerases , which stabilize (AR) ...